ALDH18A1 and hepatocellular carcinoma: Previous studies have demonstrated elevated P5CS expression in various malignancies, including hepatocellular carcinoma, where it plays a pivotal role in tumor metabolic remodeling and progression, correlating with poor patient prognosis [42, 43].